Yahoo
NasdaqGS - Nasdaq Real Time Price USD

Rigel Pharmaceuticals, Inc. (RIGL)

51.31 -0.14 (-0.27%)
At close: October 30 at 4:00:00 PM EDT
49.65 -1.66 (-3.24%)
After hours: October 30 at 6:58:28 PM EDT
Trade RIGL on Coinbase
View in AlphaSpace Currency in USD All numbers in thousands
Financial statements are getting an update on November 9
Preview it now to see what’s changing.
Learn more
Breakdown
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Total Revenue
276,785
294,282
179,278
116,882
120,242
Cost of Revenue
23,839
19,621
18,647
7,110
1,749
Gross Profit
252,946
274,661
160,631
109,772
118,493
Operating Expense
165,896
149,195
136,439
130,263
172,723
Operating Income
87,050
125,466
24,192
-20,491
-54,230
Net Non Operating Interest Income Expense
-1,474
-3,639
-5,826
-4,600
-3,023
Other Income Expense
--
--
--
--
-1,320
Pretax Income
85,576
121,827
18,366
-25,091
-58,573
Tax Provision
-236,333
-245,197
881
0
0
Net Income Common Stockholders
321,909
367,024
17,485
-25,091
-58,573
Diluted NI Available to Com Stockholders
321,909
367,024
17,485
-25,091
-58,573
Basic EPS
17.82
20.40
0.99
-1.44
-3.40
Diluted EPS
16.89
19.48
0.99
-1.44
-3.40
Basic Average Shares
18,301.50
17,987
17,579
17,401
17,240.60
Diluted Average Shares
19,565.50
18,840
17,687
17,401
17,240.60
Total Operating Income as Reported
87,050
125,466
24,192
-20,491
-55,550
Total Expenses
189,735
168,816
155,086
137,373
174,472
Net Income from Continuing & Discontinued Operation
321,909
367,024
17,485
-25,091
-58,573
Normalized Income
321,909
367,024
17,485
-25,091
-57,254.32
Interest Income
4,331
3,681
2,092
2,272
684
Interest Expense
5,805
7,320
7,918
6,872
3,707
Net Interest Income
-1,474
-3,639
-5,826
-4,600
-3,023
EBIT
91,381
129,147
26,284
-18,219
-54,866
EBITDA
94,030
131,562
28,512
-16,981
-53,868
Reconciled Cost of Revenue
23,839
19,621
18,647
7,110
1,749
Reconciled Depreciation
2,649
2,415
2,228
1,238
998
Net Income from Continuing Operation Net Minority Interest
321,909
367,024
17,485
-25,091
-58,573
Total Unusual Items Excluding Goodwill
0
--
0
0
-1,320
Total Unusual Items
0
--
0
0
-1,320
Normalized EBITDA
94,030
131,562
28,512
-16,981
-52,548
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
-1.32
12/31/2022 - 11/29/2000

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: